|
| Biotinylated Human CLEC2D Protein (LTP10190) |
|
| LTP10190 |
|
| 100ug |
|
|
$789 In stock |
| C-type lectin domain family 2, member D (CLEC2D) is implicated in the immune response. Pre-eclampsia and HIV infection have opposing immune responses. The contrasting expression of CLEC2D in HIV infection and pre-eclampsia is demonstrative of the immunosuppressive and pro-inflammatory roles of the respective pathologies. |
| Recombinant Biotinylated Human CLEC2D Protein is expressed from Expi293 with hFc tag and Avi tag at the N-terminal. It contains Arg60-Val191. |
|
| CLEC2D |
|
| Human |
|
| Q9UHP7-1 |
|
| Arg60-Val191 |
|
| The protein has a predicted MW of 59.1 kDa. Due to glycosylation, the protein migrates to 68-75 kDa based on the Tris-Bis PAGE result. |
|
| 0 |
|
| N-hFc-Avi |
|
| Expi293 |
|
| > 95% as determined by Tris-Bis PAGE; > 95% as determined by HPLC |
|
| Less than 1EU per ug by the LAL method. |
|
| Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as a protectant before lyophilization. |
|
| Reconstituted protein stable at -80 C for 12 months, 4 C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
|
| Shipped at ambient temperature. |
|
| Centrifuge tubes before opening. Reconstituting to a concentration of more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water. |
|
|  |
